Latest News about General
Recent news which mentions General
From Benzinga
From Benzinga
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
November 20, 2024
From Benzinga
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
November 20, 2024
From Benzinga
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
From Benzinga
What's Going On With C3.ai Stock Wednesday?
November 20, 2024
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
November 20, 2024
From Benzinga
From Benzinga
'Trump-Elon Trade' Lifts Space Stocks Higher
November 20, 2024
From Benzinga
What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?
November 20, 2024
From Benzinga
Starfield Reaches 15 Million Players With Updates, New Content
November 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
